EA200801251A1 - Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма - Google Patents

Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма

Info

Publication number
EA200801251A1
EA200801251A1 EA200801251A EA200801251A EA200801251A1 EA 200801251 A1 EA200801251 A1 EA 200801251A1 EA 200801251 A EA200801251 A EA 200801251A EA 200801251 A EA200801251 A EA 200801251A EA 200801251 A1 EA200801251 A1 EA 200801251A1
Authority
EA
Eurasian Patent Office
Prior art keywords
adsorbed
vaccines against
aluminum adjuvants
against flu
admission
Prior art date
Application number
EA200801251A
Other languages
English (en)
Other versions
EA014190B1 (ru
Inventor
Энтони Коулгейт
Филип Сайзер
Original Assignee
Новартис Вэксинс Энд Диагностикс Срл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0522601A external-priority patent/GB0522601D0/en
Application filed by Новартис Вэксинс Энд Диагностикс Срл filed Critical Новартис Вэксинс Энд Диагностикс Срл
Publication of EA200801251A1 publication Critical patent/EA200801251A1/ru
Publication of EA014190B1 publication Critical patent/EA014190B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

Антигенный и адъювантный компоненты вакцины против гриппа с адъювантом, не смешивают во время получения, а изготавливаются как отдельные компоненты для смешения в момент использования, например, в виде набора, состоящего из: (i) антигенного компонента, включающего антиген вируса гриппа; и (ii) адъювантного компонента, включающего соль алюминия.
EA200801251A 2005-11-04 2006-11-06 Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма EA014190B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0522601A GB0522601D0 (en) 2005-11-04 2005-11-04 Adjuvanted influenza vaccines and kits
US73560505P 2005-11-09 2005-11-09
PCT/GB2006/004138 WO2007052060A1 (en) 2005-11-04 2006-11-06 Influenza vaccines extemporaneously adsorbed to aluminium adjuvants

Publications (2)

Publication Number Publication Date
EA200801251A1 true EA200801251A1 (ru) 2008-12-30
EA014190B1 EA014190B1 (ru) 2010-10-29

Family

ID=37743954

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801251A EA014190B1 (ru) 2005-11-04 2006-11-06 Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма

Country Status (10)

Country Link
US (1) US7959931B2 (ru)
EP (1) EP1957104B1 (ru)
JP (1) JP5005700B2 (ru)
KR (1) KR101211386B1 (ru)
AU (1) AU2006310341B2 (ru)
CA (1) CA2628333C (ru)
CY (1) CY1112786T1 (ru)
EA (1) EA014190B1 (ru)
PL (1) PL1957104T3 (ru)
WO (1) WO2007052060A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013129961A1 (ru) * 2012-02-28 2013-09-06 Общество с ограниченной ответственностью "НТфарма" Рекомбинантная трехвалентная вакцина от гриппа человека

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
ES2792398T3 (es) * 2005-11-04 2020-11-11 Seqirus Uk Ltd Vacunas adyuvantadas con antígenos de no virión preparadas a partir de virus de la gripe cultivados en cultivo celular
EP1783210A1 (en) * 2005-11-08 2007-05-09 ProBioGen AG Productivity augmenting protein factors, novel cell lines and uses thereof
US8685654B2 (en) 2007-12-24 2014-04-01 Novartis Ag Assays for adsorbed influenza vaccines
GB0905570D0 (en) * 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
DK2396032T3 (en) 2009-02-10 2016-12-19 Seqirus Uk Ltd Influenza vaccines with reduced amounts of squalene
GB0919117D0 (en) * 2009-10-30 2009-12-16 Glaxosmithkline Biolog Sa Process
SG181096A1 (en) * 2009-12-03 2012-07-30 Novartis Ag Circulation of components during microfluidization and/or homogenization emulsions
JP5896359B2 (ja) * 2013-04-16 2016-03-30 清忠 安井 医薬製剤及びその製造方法
WO2014207956A1 (ja) * 2013-06-24 2014-12-31 Yasui Kiyotada 医薬製剤の製造方法及び医薬製剤キット
KR102092304B1 (ko) * 2018-03-30 2020-03-23 한국생명공학연구원 폴리감마글루탐산 및 알럼을 포함하는 면역보강제 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408615B (de) * 1998-09-15 2002-01-25 Immuno Ag Neue influenzavirus-impfstoffzusammensetzung
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013129961A1 (ru) * 2012-02-28 2013-09-06 Общество с ограниченной ответственностью "НТфарма" Рекомбинантная трехвалентная вакцина от гриппа человека

Also Published As

Publication number Publication date
CA2628333C (en) 2014-01-28
KR101211386B1 (ko) 2012-12-13
KR20080066861A (ko) 2008-07-16
EA014190B1 (ru) 2010-10-29
EP1957104A1 (en) 2008-08-20
CY1112786T1 (el) 2016-02-10
JP5005700B2 (ja) 2012-08-22
CA2628333A1 (en) 2007-05-10
US20090202590A1 (en) 2009-08-13
PL1957104T3 (pl) 2012-08-31
AU2006310341B2 (en) 2011-01-06
AU2006310341A1 (en) 2007-05-10
EP1957104B1 (en) 2012-03-21
US7959931B2 (en) 2011-06-14
WO2007052060A1 (en) 2007-05-10
JP2009514843A (ja) 2009-04-09

Similar Documents

Publication Publication Date Title
EA200801251A1 (ru) Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма
EP2377552A3 (en) Influenza vaccines with reduced amount of emulsion adjuvant
ATE331530T1 (de) Proteasom-influenzavirus-impfstoffzusammensetzu g
ATE513561T1 (de) Veränderung des th1/th2-gleichgewichts in spalt- grippeimpfstoffen mit adjuvantien
CR11122A (es) Vacuna de influenza de emulsion de aceite en agua
CY1120328T1 (el) Συνθεση εμβολιου περιεχουσα συνθετικο ανοσοενισχυτικο
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CY1117874T1 (el) Χρηση ενος ιου γριπης και ενος ανοσοενισχυτικου γαλακτωματος ελαιου-σε-νερο για την προκλιση αποκρισης των cd4 τ-κυτταρων και/ή βελτιωμενη αποκριση των β-κυτταρων μνημης
CY1112572T1 (el) Εμβολια γριπης που περιλαμβανουν συνδυασμους σωματιδιακων ανοσοενισχυτικων και ανοσοδιεγερτες
CY1113738T1 (el) Εμβολια κατα της γριπης χαμηλης περιεκτικοτητας σε προσθετα
ATE419008T1 (de) Adjuvante zusammensetzung und anwendungsverfahren dafür
EP2377551A3 (en) Adjuvanted influenza vaccines including cytokine-inducing agents
EA201070329A1 (ru) Векторы и конструкции для доставки гриппозного антигена
WO2007052061A3 (en) Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines
NO20062579L (no) Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener
GB2429711A (en) Heart and skeletal muscle inflammation (HSMI) virus
CY1109344T1 (el) Εμβολιο αδρανοποιημενου nodavirus
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
EP2368572A3 (en) Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
EA201200538A1 (ru) Арабиногалактан для повышения приобретенного иммунного ответа
ATE550034T1 (de) Extemporär auf aluminium-adjuvantien adsorbierte grippeimpfstoffe
ITRM20040066A1 (it) Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1.
AR088908A1 (es) Vacuna
NZ567982A (en) Influenza vaccines extemporaneously adsorbed to aluminium adjuvants
EA202190351A1 (ru) Композиция, входящая в состав вакцины против гриппа

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU